1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. ADC Therapeutics SA (ADCT)
  7. Quote


ADC Therapeutics Stock Price

-0.44 (-1.94%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 35,519
Bid Price
Ask Price
News -
Day High 22.64


52 Week Range


Day Low 21.87
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
ADC Therapeutics SA ADCT NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.44 -1.94% 22.20 17:00:01
Open Price Low Price High Price Close Price Prev Close
22.64 21.87 22.64 22.20 22.64
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
647 35,519 $ 22.25 $ 790,188 - 20.01 - 38.34
Last Trade Time Type Quantity Stock Price Currency
17:00:00 1,514 $ 22.20 USD


Draw Mode:

ADC Therapeutics SA Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.74B 78.27M 31.11M $ - $ - -3.57 -7.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

ADC Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADCT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.4624.8221.2622.29168,773-2.26-9.24%
1 Month28.8032.0021.2627.72214,618-6.60-22.92%
3 Months29.2532.0021.2627.34172,890-7.05-24.1%
6 Months20.7132.0020.1525.36233,8901.497.19%
1 Year35.9338.3420.0126.73271,637-13.73-38.21%
3 Years30.0056.589920.0129.91255,164-7.80-26.0%
5 Years30.0056.589920.0129.91255,164-7.80-26.0%

ADC Therapeutics Description

ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ADCT-402, ADCT-301, ADCT-602, and ADCT-601.

Your Recent History
ADC Therap..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.